Polyhydroxyalkanoates: Materials for Delivery Systems

References

• Dawes E. A. Polyhydroxybutyrate, an intriguing biopolymer. Biosci. Rep 1988; 8: 537–547
   PubMed Web of Science ®Google Scholar
• Lee S. Y. Plastic bacteria? Progress and prospects for polyhydroxyalkanoate production in bacteria. TIBTECH 1996; 14: 431–438
   Web of Science ®Google Scholar
• Müller H. -M., Seebach D. Poly(hydroxyalkanoates): a fifth class of physiologically important organic biopolymers?. Angew. Chim. Intl. Ed. Engl 1993; 32: 477–502
   Web of Science ®Google Scholar
• Steinbüchel A., Valentin H. Diversity of bacterial polyhydrox-yalkanoic acids. FEMS Microbiol. Lett 1995; 128: 219–228
   Web of Science ®Google Scholar
• Poirier Y., Nawrath C., Somerville C. Production of polyhydrox-yalkanoates, a family of biodegradable plastics and elastomers, in bacteria and plants. Bio/Technology 1995; 13: 142–150
   PubMed Web of Science ®Google Scholar
• Reusch R. N. Poly-β-hydroxybutyrate/calcium polyposphate complexes in eukaryotic membranes. Proc. Soc. Exp. Biol. Med 1989; 191: 377–381
   PubMed Web of Science ®Google Scholar
• Reusch R. N. Low molecular weight complexed poly(3-hydroxybutyrate): a dynamic and versatile molecule in vivo. Can. J. Microbiol 1995; 41(Suppl. 1)50–54
   PubMed Web of Science ®Google Scholar
• Huang R., Reusch R. N. Poly(3-hydroxybutyrate) is associated with specific proteins in the cytoplasm and membranes of Escherichia coli. J. Biol. Chem 1996; 271: 22196–22202
   PubMed Web of Science ®Google Scholar
• Jackson D. E., Srienc F. Novel methods to synthesize polyhydroxyalkanoates. Ann. N. Y. Acad. Sci 1994; 745: 134–148, Biochem. Eng. VII
   PubMed Web of Science ®Google Scholar
• Rosato D. V. Biocompatible Polymers, Metals, and Composites, M. Szycher. Technomic Publ, Lancaster, PA 1983
   Google Scholar
• Williams D. F. Definitions in biomaterials: Proceedings of a consensus conference of the European society for Biomaterials. Elsevier, New York 1987
   Google Scholar
• Engelberg I., Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991; 12: 290–304
   Web of Science ®Google Scholar
• Grijpma D. W., Zondervan G. J., Pennings A. J. High molecular weight copolymers of L-lactide and e-caprolactone as biodegradable elastomeric implant materials. Polym. Bull 1991; 25: 327–333
   Web of Science ®Google Scholar
• Grijpma D. W., Pennings A. J. Polymerization temperature effects on the properties of L-lactide and e-caprolactone copolymers. Polym. Bull 1991; 25: 335–341
   Web of Science ®Google Scholar
• Ratner B. D., Hoffman A. S., Schoen F. J., Lemons J. E. Biomaterials science: An introduction to materials in medicine. Academic, New York 1996
   Google Scholar
• Mathiowitz E., Jacob J. S., Jong Y. S., Carino G. P., Chickering D. E., Chaturvedi P., Santos C. A., Vijayaraghavan K., Montgomery S., Bassett, Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature 1997; 386: 410–414
   PubMed Web of Science ®Google Scholar
• Domb A. J., Mathiowitz E., Ron E., Giannos S., Langer R. Polyanhydrides, IV: unsaturated and crosslinked polyanhydrides. J. Polym. Sci., Part A., Polym. Chem 1991; 29: 571–579
   Web of Science ®Google Scholar
• Campbell P., Glover G. L., Gunn J. M. Inhibition of intracellular protein degradation by pepstatin, poly(L-lysine) and pepstatinyl-poly(L-lysine). Arch. Biochem. Biophys 1980; 203: 676–680
   PubMed Web of Science ®Google Scholar
• Van Heeswijk W. A. R., Hoes C. J. T., Stoffer T., Eenink M. J. D., Potman W., Feijen J. The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin, Part 1. J. Controlled Release 1985; 1: 301–315
   Google Scholar
• Holland S. J., Tighe B. J., Gould P. L. Polymers for biodegradable medical devices, 1: the potential of polyesters as controlled macro-molecular release systems. J. Controlled Release 1986; 4: 155–180
   Google Scholar
• Marchessault R. H., Morikawa H., Revol J. F., Bluhm T. L. Physical properties of a naturally occuring biopolyester: poly(β-hydroxybutyrate)/poly(β-hydroxyvalerate). Macromolecules 1984; 17: 1882–1887
   Web of Science ®Google Scholar
• Lehninger A. L. Biochemistry, 2d ed. Worth, New York 1975; 831–845
   Google Scholar
• Zubay G. Biochemistry, 2d ed. Macmillan, New York 1988; 610–611
   Google Scholar
• Pawan G. L. S., Semple S. J. G. Effect of 3-hydroxybutyrate in obese subjects on very-low-energy diets and during therapeutic starvation. Lancet 1983; 15–17
   PubMed Web of Science ®Google Scholar
• Koosha E., Muller R. H., Davis S. S. Polyhydroxybutyrate as a drug carrier. Crit. Rev. Therapeut. Drug Carrier Systems 1989; 6: 117–130
   PubMed Web of Science ®Google Scholar
• Doyle C., Tanner E. T., Bonfield W. In vitro and in vivo evaluation of PHB and of PHB replaced with hydroxypapitate. Biomaterials 1991; 12: 841–847
   PubMed Web of Science ®Google Scholar
• Embleton J. K., Tighe B. J. Polymers for biodegradable medical devices, IX: microencapsulation studies; effects of polymer composition and process parameters on poly-hydroxybutyrate-hydroxyvalerate microcapsule morphology. J. Microencapsul 1992a; 9: 73–87
   PubMed Web of Science ®Google Scholar
• Embleton J. K., Tighe B. J. Polymers for biodegradable medical devices, X: microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending. J. Microencapsul 1993; 10: 341–352
   PubMed Web of Science ®Google Scholar
• Embleton J. K., Tighe B. J. Regulation of polyester microcapsule morphology. Drug Targetting and delivery (microencapsulation of drugs), T. Whately. Harwood Academic, Philadelphia, PA 1992b; 45–54
   Google Scholar
• Knowles J. C., Hastings G. W. In vitro degradation of a PHB/PHV copolymer and a new technique for monitoring early surface changes. Biomaterials 1991; 12: 210–214
   PubMed Web of Science ®Google Scholar
• Miller N. D., Williams D. F. On the biodegradation of poly-β-hydroxybutyrate (PHB) homopolymer and poly-β-hydroxybutyrate-hydroxyvalerate copolymers. Biomaterials 1987; 8: 129–137
   PubMed Web of Science ®Google Scholar
• Yasin M., Holland S. J., Jolly A. M., Tighe B. J. Polymers for biodegradable medical devices, VI: hydroxybutyrate-hydroxyvalerate copolymers: accelerated degradation of blends with polysaccharides. Biomaterials 1989; 10: 400–412
   PubMed Web of Science ®Google Scholar
• Atkins T. W., Peacock S. J. In vitro biodegradation of polyhydroxybutyrate-hydrooxyvalerate microcapsules exposed to Hank's buffer, newborn calf serum, pancreatin and synthetic gastric juice. J. Micoencapsul 1997; 14: 35–49
   PubMed Web of Science ®Google Scholar
• Behrend D., Michalik I., Kramp B., Haubold A., Schmitz K. P. Changes in physicochemical properties of poly-β-hydroxybutyrate after long-term implantation in the rat. 23rd Meeting of the Society for Biomaterials, New Orleans, LA, 30 April-4 May, 1997
   Google Scholar
• Bissery M. -C, Valeriote F., Thies C. In vitro and in vivo evaluation of CCNU-loaded microspheres prepared from poly((β)-lactide) and poly(β-hydroxybutyrate). Microspheres and drug therapy: Pharmaceutical, immunological and medical aspects, S. S. Davis, L. Illum, J. G. McVie, E. Tomlinson. Elsevier Science, New York 1984; 217–227
   Google Scholar
• Juni K., Nakano M., Kubota M. Controlled release of aclarubicin, an anticancer antibiotic, from poly-β-hydroxybutyric acid microspheres. J. Controlled Release 1986; 4: 25–32
   Google Scholar
• Kawaguchi T., Tsugane A., Higashide K., Endoh H., Hasegawa T., Kanno H., Seki T., Juni K., Fukushima S., Nakano M. Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacy1–5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. J. Pharmaceut. Sci 1992; 81: 508–512
   PubMed Web of Science ®Google Scholar
• Gangrade N., Price J. C. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. J. Microencapsul 1991; 8: 185–202
   PubMed Web of Science ®Google Scholar
• Brophy M. R., Deasy P. B. In vitro and in vivo studies on biodegradable polyester microparticles containing sulfamethizole. Int. J. Pharmaceut 1986; 29: 223–231
   Web of Science ®Google Scholar
• Gürsel I., Hasirci V. Properties and drug release behavior of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules. J. Microencapsul 1995; 12: 185–193
   PubMed Web of Science ®Google Scholar
• Saad B., Ciardelli G., Matter S., Welti M., Uhlschmid G. K., Neuenschwander P., Suter U. W. Characterization of the cell response of cultured macrophages and fibroblasts to panicles of short-chain poly[(R)-3-hydroxybutyric acid]. J. Biomed. Materials Res 1996; 30: 429–439
   PubMed Web of Science ®Google Scholar
• Rivard C. H., Chaput C., Rhalmi S., Selmani A. Bio-absorbable synthetic polyesters and tissue regeneration: a study of three-dimensional proliferation of ovine chondrocytes and osteoblasts. Ann. Chir 1996; 50: 651–658
   PubMedGoogle Scholar
• Deasy P. B. Microencapsulation and related drug processes. Dekker, New York 1984
   Google Scholar
• Allen T. A. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends in Pharm. Sci 1994; 15: 215–220
   PubMed Web of Science ®Google Scholar
• Kubota M., Nakano M., Juni K. Mechanism of enhancement of the release rate of alcarubicin from poly-β-hydroxybutyric acid microspheres by fatty acid esters. Chem. Pharmaceut. Bull 1988; 36: 333–337
   PubMed Web of Science ®Google Scholar
• Abe H., Doi Y., Yamamoto Y. Controlled release of lastet, an anticancer drug, from poly(3-hydroxybutyrate) microspheres containing acylglycerols. Macromol. Rep 1992; A29(Suppl. 3)229–235
   Google Scholar
• Derman R. Oral contraceptives: a reassessment. Obstet. Gynecol. Surv 1989; 44: 662–668
   PubMedGoogle Scholar
• Drife J. O. New developments on contraception. Progr. Obstet. Gynaecol 1989; 7: 249–261
   Google Scholar
• Chetkowski R., Meldrum D. R. Biologic effects of transdermal estradiol. N. Engl. J. Med 1986; 314: 1615–1620
   PubMed Web of Science ®Google Scholar
• Hallagan J. B., Hallagan L. E., Snyder M. Anabolic-androgenic steroid use by athletes. N. Engl. J. Med 1989; 321: 1042–1046
   PubMed Web of Science ®Google Scholar
• Williams J. K., Adams M. R. Estrogens, progestins and coronary artery reactivity. Nat. Med 1997; 3: 273–274
   PubMed Web of Science ®Google Scholar
• Eldridge J. H., Hammond C. J., Meulbrook J. A., Staas J. K., Gilley R. M., Tice T. R. Controlled vaccine release in the gut-associated lymphoid tissues, I: Orally administered biodegradable microspheres target the Payer's patches. J. Controlled Release 1990; 11: 205–214
   Web of Science ®Google Scholar
• Gerngross T. U., Martin D. P. Enzyme-catalyzed synthesis of poly[(R)-(-)-3-hydroxybutyrate]: formation of macroscopic granules in vitro. Proc. Natl. Acad. Sci. USA 1995; 92: 6279–6283
   PubMed Web of Science ®Google Scholar
• Omri A., Ravaoarinoro M., Poisson M. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa. J. Antimicrob. Chemother 1995; 36: 631–639
   PubMed Web of Science ®Google Scholar